Alvin Darby, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 200 S Lewis St, New Iberia, LA 70560 Phone: 337-321-4168 Fax: 337-321-6275 |
Dr. Therese L. Ritter, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 516 Jefferson Ter, Suite 200, New Iberia, LA 70560 Phone: 337-364-0077 Fax: 337-364-0877 |
Dr. Wayne T Lindemann, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 600 N Lewis St, New Iberia, LA 70563 Phone: 337-255-8911 |
News Archive
The Pulmonary Fibrosis Foundation and Veracyte, Inc. announced that the organizations are partnering on a U.S. patient survey to advance understanding of patients' diagnostic experiences with interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF).
A team of scientists from the UC San Diego School of Medicine and Osaka University in Japan have identified a protein switch that helps prevent liver damage, including inflammation, fibrosis and cancer. The findings suggest that a better understanding of how the protein, TAK1, works could lead to new insights into the development of liver disease and cancer.
States eased those policies based on politics as much as COVID-19 death rates or case counts, according to new research from the University of Washington. The researchers also found that states with large Black communities, despite those communities being hit hardest by the pandemic, also lifted restrictions earlier.
Pfizer announced today that the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion regarding the marketing authorization of axitinib in the European Union (EU), for the treatment of adult patients with advanced renal cell carcinoma (RCC), a type of advanced kidney cancer, after failure of prior treatment with sunitinib or a cytokine.
A new capsule form of faecal microbiota transplantation (FMT) has raised hopes that this effective treatment for Clostridium difficile (C. difficile) infection and other bowel conditions might soon become mainstream. A recently-reported study confirmed that capsules containing a frozen suspension of faecal material harvested from healthy unrelated donors was well tolerated and effectively resolved diarrhoea in 90% of patients with difficult-to-treat C. difficile infection.
› Verified 5 days ago